Intra-Host SARS-CoV-2 Evolution in the Gut of Mucosally-Infected Chlorocebus aethiops (African Green Monkeys)

Viruses. 2022 Jan 1;14(1):77. doi: 10.3390/v14010077.

Abstract

In recent months, several SARS-CoV-2 variants have emerged that enhance transmissibility and escape host humoral immunity. Hence, the tracking of viral evolutionary trajectories is clearly of great importance. Little is known about SARS-CoV-2 evolution in nonhuman primate models used to test vaccines and therapies and to model human disease. Viral RNA was sequenced from rectal swabs from Chlorocebus aethiops (African green monkeys) after experimental respiratory SARS-CoV-2 infection. Two distinct patterns of viral evolution were identified that were shared between all collected samples. First, mutations in the furin cleavage site that were initially present in the virus as a consequence of VeroE6 cell culture adaptation were not detected in viral RNA recovered in rectal swabs, confirming the necessity of this motif for viral infection in vivo. Three amino acid changes were also identified; ORF 1a S2103F, and spike D215G and H655Y, which were detected in rectal swabs from all sampled animals. These findings are demonstrative of intra-host SARS-CoV-2 evolution and may identify a host-adapted variant of SARS-CoV-2 that would be useful in future primate models involving SARS-CoV-2 infection.

Keywords: African green monkey (Chlorocebus aethiops); SARS-CoV-2; evolution.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • COVID-19 / virology*
  • Chlorocebus aethiops
  • Disease Models, Animal
  • Evolution, Molecular
  • Mutation
  • Polyproteins / genetics
  • RNA, Viral / genetics
  • Rectum / virology
  • SARS-CoV-2 / genetics*
  • Spike Glycoprotein, Coronavirus / genetics
  • Vero Cells
  • Viral Proteins / genetics

Substances

  • ORF1ab polyprotein, SARS-CoV-2
  • Polyproteins
  • RNA, Viral
  • Spike Glycoprotein, Coronavirus
  • Viral Proteins
  • spike protein, SARS-CoV-2